Conditions: Crohn's Disease
Keywords: Crohn's disease, moderate, severe, active, AIN457
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 59
Healthy volunteers: no

Brief summary:
This study will assess the safety and efficacy of AIN457 in patients with moderate to severe active Crohn's disease.

Detailed description:

Arms:
arm 1: AIN457 10 mg/kg was given as an intravenous infusion at day 1 and day 22. arm 2: Matching placebo to AIN457 was given as an infusion at day 1 and day 22.

Interventions: intervention 1: AIN457 intervention 2: Placebo
Intervention descriptions: intervention 1: 10 mg/kg intervention 2: Matching placebo to AIN457

Protocol document: